Arabesque Asset Management’s Tandem Diabetes Care TNDM Stock Holding History

Arabesque Asset Management’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-22,148	Closed	-$1.31M	–	155
2019 Q3	$1.31M	Buy	+22,148	New	+$1.41M	0.6%	78
2019 Q2	–	Sell	-50,753	Closed	-$3.22M	–	135
2019 Q1	$3.22M	Buy	+50,753	New	+$2.67M	1.66%	22

Other funds holding TNDM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return

Arabesque Asset Management's TNDM Position: Q4 2019 in Review

Arabesque Asset Management sold out of Tandem Diabetes Care (TNDM) in Q4 2019, closing a stake of 22,148 shares — an estimated $1.31M sold.

Arabesque Asset Management first reported a position in TNDM in Q1 2019 and held it in 2 quarters. The position peaked at $3.22M in Q1 2019. 284 funds tracked by Wall St. Rank hold TNDM as of Q4 2019.

Arabesque Asset Management reported no remaining Tandem Diabetes Care position as of Q4 2019 after selling out during the quarter.
Arabesque Asset Management sold 22,148 Tandem Diabetes Care shares in Q4 2019, an estimated $1.31M.
Arabesque Asset Management first reported a position in Tandem Diabetes Care in Q1 2019 and held it in 2 quarters.
Arabesque Asset Management's Tandem Diabetes Care position peaked at $3.22M in Q1 2019.
284 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2019.

Based on Arabesque Asset Management's 13F filing for Q4 2019, filed 30 Jan 2020.